Honglei Zhang
ORCID: 0000-0002-5522-8120Also affiliated with Beijing University of Chinese Medicine, Nantong University, Chinese PLA General Hospital, Affiliated Hospital of Nantong University, United States Air Force, Shanghai East Hospital, Air Force General Hospital PLA, China Medical University
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 3 papers. Top paper: “Zanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation”.
Jacob Soumerai, Jeremy S. Abramson, Jeffrey A. Barnes, Philip Caron, Shalini Chhabra +23 more
Jingxin Qiao, Chaemin Yoon, Guo Zhang, Yuxin Hou, Xiaoyan Xia +32 more
Xiuting Wang, Yaqin Li, Ying Bai, Qi Li, Shuling Wang +5 more